Analysis

As Featured In

Bespoke Sector Analysis

May 6, 2020
Categories
Moderna and Lonza Announce Worldwide Collaboration to Manufacture vaccine against COVID-19
Do you like it?
Read more
February 4, 2019
Categories
Cell & Gene Therapy: Increasing Demand for Viral Vectors Drives Biomanufacturing Innovation & CDMO Investment
Do you like it?
Read more
October 24, 2018
RNAi Therapeutics Come of Age: Exploring the Peaks & Troughs of Alnylam's Thirty Year Journey to First Approval
Categories
RNAi Therapeutics Come of Age: Exploring the Peaks & Troughs of Alnylam’s Thirty Year Journey to First Approval
Do you like it?
Read more
October 10, 2018
Global Drug Development IPOs: 26 Companies Raise $3.18B in Q3 as First Pre-Revenue Biotechs List on HKEX
Categories
Global Drug Development IPOs: 26 Companies Raise $3.18B in Q3 as First Pre-Revenue Biotechs List on HKEX
Do you like it?
Read more
August 10, 2018
Democratising DNA: 23andMe & GSK Collaboration Raises Privacy & Data Quality Concerns - Can Blockchain Offer a Disruptive Solution?
Categories
Democratising DNA: 23andMe & GSK Collaboration Highlights Data Quality & Privacy Concerns; Can Blockchain Offer a Disruptive Solution?
Do you like it?
Read more
July 12, 2018
Global Drug Development IPOs: NASDAQ Dominance Continues as 26 Companies Raise Over $2.54B in Q2
Categories
Global Drug Development IPOs: NASDAQ Dominance Continues as 26 Companies Raise Over $2.54B in Q2
Do you like it?
Read more
April 12, 2018
Lonza Opens World’s Largest Cell & Gene Therapy Manufacturing Plant in Texas
Categories
Lonza Opens World’s Largest Cell & Gene Therapy Manufacturing Plant in Texas
Do you like it?
Read more
March 27, 2018
Categories
All Eyes on Oxford Nanopore after further £100m funding raised at £1.5B Valuation
Do you like it?
Read more
March 8, 2018
Charles River Laboratories M&A Activity Analysis: a Differentiated Strategy Delivering Results
Categories
Charles River Laboratories M&A Activity Analysis: A Differentiated Strategy Delivering Results
Do you like it?
Read more
February 22, 2018
Making Large-Scale Biomanufacturing More Efficient and Affordable: Have Novo Nordisk Foundation Made a Major Breakthrough?
Categories
Making Large-Scale Biomanufacturing More Efficient and Affordable: Have Novo Nordisk Foundation Made a Major Breakthrough?
Do you like it?
Read more
February 20, 2018
2018 Global Drug Development IPO Review
Categories
2018 Global Drug Development IPO Analysis: $10.24B Raised in Strongest Year on Record
Do you like it?
Read more
January 30, 2018
GLOBAL DRUG DEVELOPMENT IPOs: $6.4B Raised as Bullish Investors Back Biologics & Gene Therapies Despite Slowed Growth in 2017
Categories
Global Therapeutic IPO Review: $6.4B Raised as Bullish Investors Back Biologics & Gene Therapies Despite Slowed Growth in 2017
Do you like it?
Read more
Load more
Contact Us